home / stock / surf / surf news


SURF News and Press, Surface Oncology Inc. From 11/25/19

Stock Information

Company Name: Surface Oncology Inc.
Stock Symbol: SURF
Market: NASDAQ
Website: surfaceoncology.com

Menu

SURF SURF Quote SURF Short SURF News SURF Articles SURF Message Board
Get SURF Alerts

News, Short Squeeze, Breakout and More Instantly...

SURF - Surface Oncology Announces $25 Million Debt Financing from K2 HealthVentures

CAMBRIDGE, Mass., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Surface Oncology  (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced it has secured a debt financing facility for up to $25 mil...

SURF - CRC, CGIX, XXII and PDD among midday movers

Gainers:  Cancer Genetics CGIX  +224% . More news on: Surface Oncology, Inc., Cellectar Biosciences, Inc., Magenta Therapeutics, Inc., Stocks on the move, Read more ...

SURF - YNDX, I, QD and OESX among tech movers

Gainers:  Cellcom Israel (NYSE: CEL ) +24% . More news on: Cellcom Israel Ltd., Eltek Ltd., Partner Communications Company Ltd. Read more ...

SURF - Surface Oncology Announces Filing of IND for CD39 Targeted Antibody Candidate, SRF617, at Inaugural R&D Day

Details clinical plans for phase 1/1b clinical studies of SRF617 and SRF388 in patients with advanced solid tumors Shares preclinical data for new, CD112R targeted antibody candidate, SRF813, and its ability to promote NK/T cell activation CAMBRIDGE, Mass., Nov. 18, 2019 (GLOBE NEW...

SURF - Key events next week - healthcare

Noteworthy events during the week of November 17 - 23 for healthcare investors. More news on: Resverlogix Corp., Surface Oncology, Inc., Humanigen, Inc., Healthcare stocks news, , Read more ...

SURF - Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2019

CAMBRIDGE, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today reported financial results and corporate highlights for the third quarter ...

SURF - Surface Oncology Presents Updates at the Society for Immunotherapy of Cancer's Annual Meeting

CAMBRIDGE, Mass., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Surface Oncology  (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that it will present at the Society for the Immunotherapy...

SURF - Surface Oncology to Host Analyst and Investor Day on November 18, 2019 in New York City

Keynote speaker: E. John Wherry, Ph.D., director, Penn Institute for Immunology, University of Pennsylvania, and Co-Director of the Parker Institute for Cancer Immunotherapy at Penn Presentations from Surface management to include strategic updates on current programs and introductio...

SURF - AIMT, AYI, NIO and TSG among midday movers

Gainers : The Stars Group (NASDAQ: TSG ) +29% . Naked Brand Group (NASDAQ: NAKD ) +15% . Yuma Energy (NYSEMKT: YUMA ) +15% . Surface Oncology (NASDAQ: SURF ) +14% . Catalyst Biosciences (NASDAQ: CBIO ) +13% . NIO (NYSE: NIO ) +13% . Zynex (NASDAQ: ZYXI ) +11% . Aimmune Therapeutics ...

SURF - ENDP, INMD, LTM and NXTC among midday movers

Gainers:  LATAM Airlines Group (NYSE: LTM ) +30% . Just Energy Group (NYSE: JE ) +26% . Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ) +20% . Tiziana Life Sciences PLC (NASDAQ: TLSA ) +20% . Contango Oil & Gas Company (NYSEMKT: MCF ) +14% . Ra Medical Systems, Inc. (NYSE: R...

Previous 10 Next 10